Dow Jones Top Company Headlines at 1 PM ET: Novo Nordisk Cuts Prices for Obesity Drugs | Deutsche ... The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for ...

Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.

Novo Holdings will sell its stake of around 7.8% in medical-device maker Convatec.

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on ...

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

A conservative group led by Mike Pence allies opposes Trump's Most-Favored-Nation drug pricing agreements with Eli Lilly and ...

New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.

Novo Holdings, which controls obesity drugmaker Novo Nordisk , will sell 154.5 million shares, or 7.8% of its stake, in ...

Novo Nordisk is lowering the price it charges customers who pay out-of-pocket for the weight loss drugs. Mr. Funk was the ...

The cash price for popular weight-loss medication Wegovy is dropping by 30% in U.S. on Monday, according to Novo Nordisk.

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...